Gastroenterology and Hepatology - Issue 1/2024
Clinical and Experimental Gastroenterology: Review Article
41
Hidradenitis suppurativa, intestinal microbiome and SIBO – a comprehensive overview of the issue
B. Ivanková, J. Baloghová
Editorial
3
Editorial
M. Lukáš
5
Heuréka!
M. Bortlík
Quiz
IBD
13
Doporučení Pracovní skupiny pro idiopatické střevní záněty pro diagnostiku Crohnovy choroby
M. Bortlík-, D. Ďuricová, P. Drastich, V. Mandys, Z. Šerclová, N. Machková, A. Novotný, K. Mareš, J. Stehlík, M. Lukáš Za Pracovní Skupinu Pro Ibd Čgs Čls Jep
19
Reduced urinary magnesium levels after ileocolic resection in patients with Crohn’s disease
V. Navrátil, Lumír Kunovský, B. Pipek, Jan Křivinka, J. Zapletalová, Přemysl Falt
31
Efficacy and safety of switching from intravenous to subcutaneous CTP-13 treatment in IBD patients – a one-year retrospective study from large Slovak IBD centre
A. Gojdičová, I. Sturdik, J. Tóth, M. Gojdič, Z. Vrablicová, I. Čierna, D. Székyová, A. Krónerová, T. Hlavatý
Digestive Endoscopy: Case Report
47
Idiopathic hypereosinophilic syndrome with gastrointestinal involvement
D. Husáková, Š. Konečný
53
Simultaneous robotic resection of colorectal cancer and liver metastases – first experience
V. Teplan, J. Chrobok, A. M. Rulseh, R. Pospíšil
Others
Gastroenterology and Hepatology
2024 Číslo 1
Najčítanejšie v tomto čísle
- Mirikizumab – the first anti-IL23 p19 antibody in ulcerative colitis therapy
- Hidradenitis suppurativa, intestinal microbiome and SIBO – a comprehensive overview of the issue
- Idiopathic hypereosinophilic syndrome with gastrointestinal involvement
- Methotrexate is the re-discovered drug for Crohn’s disease